On November 3, 1906, the German clinical psychiatrist and neuroanatomist Alois Alzheimer reported “A...
Lumipulse® G β-Amyloid 1-40 CSF
Immunoreaction cartridges for research use with the LUMIPULSE G Analyzer for the quantitative measurement of β-amyloid 1-40 in human cerebrospinal fluid. (CSF)
The Lumipulse G β-Amyloid 1-40 assay is intended to be used in conjunction with Lumipulse G β-Amyloid 1-42 assay to determine the amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) in the clinical setting of dementia diagnosis.
This CSF amyloid ratio (β-amyloid1-42 / β-amyloid1-40 ratio) is intended to be used as an aid for diagnosis in patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive decline.
The CSF amyloid ratio supports the probability of AD pathology only as an adjunct to other diagnostic evaluations.
This product is For Research Use Only (RUO), not for use in diagnostic procedures.
For research use only
Lumipulse G β-Amyloid 1-40 Immunoreaction Cartridges
Product # 231685
3 x 14 Tests
Lumipulse G β-Amyloid 1-40 Calibrators
Product # 231692
2 x 3 Concentrations
Lumipulse G β-Amyloid Controls
Product # 231708
2 x 3 Concentrations
Please contact your local Fujirebio representative for the availability of this product in your country.